Wells Fargo & Company Ideaya Biosciences, Inc. Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IDYA
# of Institutions
216Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$184 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$141 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$139 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$129 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$108 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.3B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...